Skip to content
Trial Eligibility
Menu

COPD Clinical Trials near Miami, FL

22 studies for COPD are recruiting at 81 sites within 50 miles of Miami, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all COPD trials in the US or all trials near Miami.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

COPD studies enrolling near Miami

Showing 22 studies, nearest first.
  1. Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

    NCT06961214

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: GSK Investigational Site (Miami, FL); GSK Investigational Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  2. A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

    NCT06283966

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: Research Site (Miami, FL); Research Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  3. A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    NCT07082738

    • Phase 2
    • Ages 40 years and older
    • Sex: All

    Nearest sites: Research Site (Miami, FL); Research Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  4. Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

    NCT07190222

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: DL Research Solutions- Site Number : 8400140 (Miami, FL); Elite Clinical Research - Miami- Site Number : 8400167 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  5. Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

    NCT06959095

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: GSK Investigational Site (Miami, FL); GSK Investigational Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  6. eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

    NCT07177339

    • Phase 3
    • Ages 40 to 75 years
    • Sex: All

    Nearest sites: GSK Investigational Site (Miami, FL); GSK Investigational Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  7. Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

    NCT07190209

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: MCR Research- Site Number : 8400004 (Miami, FL); My Community Research Center- Site Number : 8400164 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  8. A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

    NCT06883305

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: Research Site (Miami, FL); Research Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  9. myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

    NCT05204888

    • Interventional
    • Ages 30 years and older
    • Sex: All

    Nearest sites: NewGen Health Group (Miami, FL); Reliable Research, Inc. (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

    NCT07053423

    • Phase 4
    • Ages 40 to 85 years
    • Sex: All

    Nearest sites: Finlay Medical Research- Site Number : 8400010 (Miami, FL); University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    NCT07759245

    • Phase 2
    • Ages 40 to 75 years
    • Sex: All

    Nearest sites: Millennium Medical Research - Miami (Miami, FL); Deluxe Health Center (Miami Lakes, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

    NCT06578156

    • Interventional
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

    NCT06878261

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: Research Site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

    NCT07363694

    • Phase 2/3
    • Ages 35 to 80 years
    • Sex: All

    Nearest site: Reed Medical Research (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

    NCT07684820

    • Phase 2
    • Ages 40 to 85 years
    • Sex: All

    Nearest site: Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Rademikibart IV for Acute Asthma and COPD Exacerbation

    NCT07705737

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: Pharmax Research of South Florida, Inc. (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

    NCT07725939

    • Phase 2
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: Copd01 50011 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Alpha-1 Research Registry

    NCT04157049

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Alpha-1 Foundation (Coral Gables, FL)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. STRIVE Post-Market Registry Study

    NCT04302272

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Coral Gables, FL)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

    NCT06122077

    • Observational
    • Ages 50 years and older
    • Sex: All

    Nearest site: Universal Axon Clinical Research (Doral, FL)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

    NCT07780669

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: GSK Investigational Site (Doral, FL)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

    NCT07646587

    • Phase 2
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: WB Contracted Clinical Research Site (Miami Lakes, FL)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a COPD clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.